<DOC>
	<DOCNO>NCT02243293</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy ABT-493 ABT-530 ( ABT-493/ABT-530 ) coadministered without ribavirin adult chronic HCV genotypes 2 , 3 , 4 , 5 6 infection . In part 4 , primary objective also include assess efficacy ( SVR12 ) treatment ABT-493/ABT-530 combination regimen GT2-infected DAA-naive subject without cirrhosis compare historical SVR12 rate treatment sofosbuvir plus RBV GT2-infected DAA-naive subject without cirrhosis .</brief_summary>
	<brief_title>A Study Evaluate Efficacy , Safety , Pharmacokinetics Co-Administration ABT-493 ABT-530 With Without RBV Subjects With Chronic Hepatitis C Virus ( HCV ) Genotypes 2 , 3 , 4 , 5 6 Infection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Male female least 18 year age time Screening Screening laboratory result indicate HCV Genotype 2 , 3 , 4 , 5 , 6 infection . Chronic HCV infection . Subject must either HCV treatmentna√Øve treatmentexperienced . Subject must document noncirrhotic compensate cirrhosis ( GT3 ) . History severe , lifethreatening significant sensitivity drug . Female pregnant , plan become pregnant study , breastfeed ; male whose partner pregnant planning become pregnant study . Recent ( within 6 month prior study drug administration ) history drug alcohol abuse could preclude adherence protocol opinion investigator . Positive test result Screening hepatitis B surface antigen ( HBsAg ) antihuman immunodeficiency virus antibody ( HIV Ab ) . HCV genotype perform screen indicate coinfection one HCV genotype .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hepatitis C Virus</keyword>
	<keyword>Hepatitis C Genotype 4</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>HCV</keyword>
	<keyword>Hepatitis C Genotype 5</keyword>
	<keyword>interferon free</keyword>
	<keyword>Hepatitis C Genotype 2</keyword>
	<keyword>Hepatitis C Genotype 3</keyword>
	<keyword>Hepatitis C Genotype 6</keyword>
	<keyword>Chronic Hepatitis C</keyword>
</DOC>